Battling the top cause of death worldwide Comprehensive testing can support care for patients before and after adverse cardiac events
According to the World Health Organization, cardiovascular diseases are the number one cause of death globally, with more people dying from cardiovascular diseases each year than any other cause.1 Since hereditary and lifestyle factors can affect a patient's risk of experiencing cardiovascular disease, medical monitoring and management of patient conditions and behaviors can last for years.
Cardiovascular disease management has financial impacts. The CDC Foundation has reported that about one in every six U.S. healthcare dollars is spent on cardiovascular disease.2 By 2030, annual direct medical costs associated with cardiovascular diseases are projected to rise to more than $818 billion.3
Clinical laboratories can support care for patients experiencing, or at risk for, cardiovascular disease. Comprehensive testing, in combination with medical monitoring and treatment, can help with cardiovascular disease diagnosis, management and therapies.